Nanoparticles containing anti-cancer drugs and preparation method and application thereof
A nanoparticle and anticancer drug technology is applied to the nanoparticle containing anticancer drug, and the preparation field thereof can solve the problems of low drug loading and low bioavailability of the nano drug-carrying system, and achieve uniform morphology and cycle time. Long, good therapeutic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] Example 1: Preparation of nanoparticles comprising paclitaxel
[0039] Paclitaxel was dissolved in absolute ethanol to make a solution with a concentration of 50 mM, and 200 μL of the prepared paclitaxel absolute ethanol solution was added to 20 mL of deionized water, stirred magnetically at 25 °C for 5 min and then left to stand to obtain a precursor nanoparticle suspoemulsion.
[0040] Distearoylphosphatidylethanolamine-polyethylene glycol was formulated as a 5mg / mL aqueous solution.
[0041] Add 300 μL of 5 mg / mL distearoylphosphatidylethanolamine-polyethylene glycol aqueous solution into the precursor nanoparticle suspoemulsion, ultrasonically disperse for 5 minutes under the condition of ultrasonic power of 100%, and let it stand for 6 hours to prepare water Phase-dispersed nanoparticles comprising paclitaxel.
Embodiment 2
[0042] Example 2: Preparation of nanoparticles comprising docetaxel
[0043] Docetaxel was dissolved in tetrahydrofuran to prepare a solution with a concentration of 500 mM, and 50 μL of the prepared docetaxel tetrahydrofuran solution was added to 10 mL of deionized water, stirred magnetically at 25 °C for 30 min and then left to stand to obtain a precursor nanoparticle suspoemulsion.
[0044] Polylactic acid-polyethylene glycol was formulated into a 0.5 mg / mL aqueous solution.
[0045] Add 1mL of 0.5mg / mL polylactic acid-polyethylene glycol aqueous solution into the precursor nanoparticle suspoemulsion, ultrasonically disperse for 30min under the condition of ultrasonic power of 100%, and let it stand for 6h to prepare the aqueous phase dispersion containing Nanoparticles of docetaxel.
Embodiment 3
[0046] Example 3: Preparation of nanoparticles comprising 10-hydroxycamptothecin
[0047] Dissolve 10-hydroxycamptothecin in N,N-dimethylformamide to make a solution with a concentration of 1mM, take 500μL of the prepared 10-hydroxycamptothecin N,N-dimethylformamide solution and add it to 10mL In deionized water, stir magnetically at 20° C. for 1 min and then let stand to obtain precursor nanoparticle suspoemulsion.
[0048] Distearoylphosphatidylethanolamine-polyethylene glycol was formulated as a 10mg / mL aqueous solution.
[0049] Add 100 μL of 10 mg / mL distearoylphosphatidylethanolamine-polyethylene glycol aqueous solution into the precursor nanoparticle suspoemulsion, ultrasonically disperse for 1 min under the condition of ultrasonic power of 100%, and let it stand for 6 h to prepare water Phase-dispersed nanoparticles comprising 10-hydroxycamptothecin.
PUM
| Property | Measurement | Unit |
|---|---|---|
| length | aaaaa | aaaaa |
| length | aaaaa | aaaaa |
| width | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 